All In MedTech

Device Trial Radar · NCT02241642

Safety and Performance Study of Large Hole Vascular Closure Device

Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER II Study

Last checked: Nov 20, 2026Latest source record: Feb 1, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

65

Actual

Start

Oct 2013

Primary completion

Nov 2016

Study completion Nov 2017

Sponsor

Lead sponsor
Vivasure Medical LimitedNot on our public-company list
Sponsor type
Industry
First posted
Sep 16, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Clinical Investigation is to validate that the clinical use of the VIVASURE CLOSURE DEVICE™ is safe for the operator, patient and third parties, and to confirm its performance to percutaneously close femoral arterial puncture sites in the range of 18-24 F, post endovascular procedures. This is a non-inferiority study based on safety. Safety will be assessed by incidence and severity of major complication rates directly related to the VIVASURE CLOSURE DEVICE™ up to 3 months from implantation is no worse than those associated with cut-down and sutured close.

Conditions

  • Percutaneous Common Femoral Artery Arteriotomy Closure

Interventions

  • VIVASURE CLOSURE DEVICE™Device

    Large hole vascular closure device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary EndpointTime frame: 3 months

Locations

9 sites in 4 countries. Site status is shown where the registry gives one.

  • University Hospital Antwerp (UZA)

    Edegem, Belgium

  • The Charité - Universitätsmedizin

    Berlin, Germany

  • Vivantes Klinikum im Friedrichshain

    Berlin, Germany

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.